Related Experiment Video
Updated: Jul 13, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Three cases of endometrial cancer associated with "bioidentical" hormone replacement therapy
John A Eden1, Neville F Hacker, Michael Fortune
1University of New South Wales, Sydney, NSW, Australia. j.eden@unsw.edu.au
Abstract:
We describe three women who developed endometrial cancer after taking "bioidentical" hormone replacement therapy (HRT) to relieve menopausal symptoms. Although pharmaceutical HRT is a well established and tested therapy, little is known about the quality control, safety and efficacy of bioidentical HRT. Women should be advised to avoid bioidentical HRT, and those who continue to use it should receive regular endometrial surveillance.
Related Concept Videos
Disorders of the Female Reproductive System
Menopause
Cushing Syndrome I: Introduction
Hyperthyroidism II: Pathophysiology
Cellular Adaptation IV: Dysplasia and Metaplasia
Targeted Cancer Therapies
There are several types of targeted therapies against specific...